Republic of Moldova vs Syrian Arab Republic: Antiretroviral therapy coverage
Republic of Moldova
53.0%
in 2024
Syrian Arab Republic
55.0%
in 2024
Republic of Moldova rank
115th
Syrian Arab Republic rank
112th
Antiretroviral therapy coverage over time
- Republic of Moldova
- Syrian Arab Republic
How they compare
Syrian Arab Republic currently reports 55.0% against 53.0% in Republic of Moldova, a difference of 2.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Syrian Arab Republic ahead.
Republic of Moldova ranks 115th and Syrian Arab Republic ranks 112th of 143 countries.
Syrian Arab Republic has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Republic of Moldova | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.6% | 3.0% | 1.4% | Syrian Arab Republic |
| 2010s | 20.4% | 22.3% | 1.9% | Syrian Arab Republic |
| 2020s | 46.0% | 48.8% | 2.8% | Syrian Arab Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage, Republic of Moldova or Syrian Arab Republic?
- Syrian Arab Republic, at 55.0% against 53.0% in Republic of Moldova as of 2024.
- What is the difference in antiretroviral therapy coverage between Republic of Moldova and Syrian Arab Republic?
- 2.0%, with Syrian Arab Republic ahead.
- How many years of comparable data are there for Republic of Moldova and Syrian Arab Republic?
- 25 years are reported by both, from 2000 to 2024.
- How do Republic of Moldova and Syrian Arab Republic rank globally for antiretroviral therapy coverage?
- Republic of Moldova ranks 115th and Syrian Arab Republic ranks 112th of 143 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage (% of people living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.